Wordt geladen...
Targeting RET-rearranged non-small-cell lung cancer: future prospects
Non-small-cell lung cancer (NSCLC) patients with mutated or rearranged oncogene drivers can be treated with upfront selective inhibitors achieving higher response rates and longer survival than chemotherapy. The RET gene can undergo chromosomal rearrangements in 1%–2% of all NSCLC patients, involvin...
Bewaard in:
| Gepubliceerd in: | Lung Cancer (Auckl) |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6433115/ https://ncbi.nlm.nih.gov/pubmed/30962732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S192830 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|